« Previous
Next »
Journal of Critical Care
Volume 23, Issue 4
, Pages
484-492
, December 2008
Patient-specific decision modeling to guide the use of drotrecogin α (activated) in patients with severe sepsis
To access this article, please choose from the options below
☆ Financial support for this study was provided entirely by an unrestricted educational grant from the Eli Lilly Company. The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report. The following author is employed by the sponsor: Joseph A. Johnston, MD, MSc.
PII: S0883-9441(08)00022-1
doi: 10.1016/j.jcrc.2007.12.016
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Critical Care
Volume 23, Issue 4
, Pages
484-492
, December 2008
